메뉴 건너뛰기




Volumn 2, Issue 3, 2017, Pages 154-155

Direct-acting antiviral therapy for hepatitis E virus?

Author keywords

[No Author keywords available]

Indexed keywords

RIBAVIRIN; RNA POLYMERASE; SOFOSBUVIR; ANTIVIRUS AGENT;

EID: 85012257332     PISSN: 24681253     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2468-1253(16)30242-4     Document Type: Letter
Times cited : (10)

References (5)
  • 1
    • 84995906210 scopus 로고    scopus 로고
    • Hepatitis E: a neglected virus
    • 1 The Lancet Gastroenterology & Hepatology. Hepatitis E: a neglected virus. Lancet Gastroenterol Hepatol, 1, 2016, 261.
    • (2016) Lancet Gastroenterol Hepatol , vol.1 , pp. 261
  • 2
    • 84952719793 scopus 로고    scopus 로고
    • Sofosbuvir inhibits hepatitis E virus replication in vitro and results in an additive effect when combined with ribavirin
    • 2 Dao Thi, VL, Debing, Y, Wu, X, et al. Sofosbuvir inhibits hepatitis E virus replication in vitro and results in an additive effect when combined with ribavirin. Gastroenterology 150 (2016), 82–85.
    • (2016) Gastroenterology , vol.150 , pp. 82-85
    • Dao Thi, V.L.1    Debing, Y.2    Wu, X.3
  • 3
    • 84997112245 scopus 로고    scopus 로고
    • Distinct antiviral potency of sofosbuvir against hepatitis C and E viruses
    • 3 Wang, W, Hakim, MS, Nair, VP, et al. Distinct antiviral potency of sofosbuvir against hepatitis C and E viruses. Gastroenterology 151 (2016), 1251–1253.
    • (2016) Gastroenterology , vol.151 , pp. 1251-1253
    • Wang, W.1    Hakim, M.S.2    Nair, V.P.3
  • 4
    • 85005769258 scopus 로고    scopus 로고
    • Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infection
    • 4 van der Valk, M, Zaaijer, HL, Kater, AP, Schinkel, J, Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infection. J Hepatol 66 (2017), 242–243.
    • (2017) J Hepatol , vol.66 , pp. 242-243
    • van der Valk, M.1    Zaaijer, H.L.2    Kater, A.P.3    Schinkel, J.4
  • 5
    • 85006277752 scopus 로고    scopus 로고
    • Sofosbuvir and daclatasvir anti-viral therapy fails to clear HEV viremia and restore reactive T cells in a HEV/HCV co-infected liver transplant recipient
    • 5 Donnelly, MC, Imlach, SN, Abravanel, F, et al. Sofosbuvir and daclatasvir anti-viral therapy fails to clear HEV viremia and restore reactive T cells in a HEV/HCV co-infected liver transplant recipient. Gastroenterology 152 (2017), 300–301.
    • (2017) Gastroenterology , vol.152 , pp. 300-301
    • Donnelly, M.C.1    Imlach, S.N.2    Abravanel, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.